Mercury Pharmaceuticals

We are de-risking biomedical innovations, while turning biomedical knowledge into social and economic value.

Stay Informed!

Non-coding RNA molecules offer new ways to treat heart disease

17

Nov 2026

Non-coding RNA molecules offer new ways to treat heart disease

A review published in Genes & Diseases highlights how RNA molecules could open new avenues for diagnosing and treating heart disease. Researchers from Shandong Second Medical University and Qingdao University examine four groups of non-coding RNAs that influence abnormal heart muscle growth, damage caused by reduced blood supply, and heart failure.

Kangaroo care reduces newborn mortality and serious hospital infections

17

Nov 2026

Kangaroo care reduces newborn mortality and serious hospital infections

Kangaroo care, an approach to care in which low birthweight and preterm babies are held skin-to-skin against a caregiver's chest, receive frequent and exclusive breastfeeding and are discharged early from hospital when appropriate, probably reduces deaths and serious infections compared with conventional neonatal care.

Kangaroo care reduces newborn mortality and serious hospital infections

17

Nov 2026

Kangaroo care reduces newborn mortality and serious hospital infections

Kangaroo care, an approach to care in which low birthweight and preterm babies are held skin-to-skin against a caregiver's chest, receive frequent and exclusive breastfeeding and are discharged early from hospital when appropriate, probably reduces deaths and serious infections compared with conventional neonatal care.

MERCURY trials

Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more

Cancer

Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more

Neuroscience

Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more

Mercury Pharmaceuticals

Why Us?

Strong experience in academic research and technology transfer makes us understand your goals and motivations as a technology originator.
Our experience in drug development from discovery to clinical and commercial stages makes us an insider player within the biopharmaceutical industry.
Smart approach to project management that helps speed up development stages and decision making.
Availability of own investment up to 2m€ per project allows us to reach the next value milestone.